Epigenetics Regulation of Lung Cancer: Implications for Clinical Doctor

被引:0
|
作者
Rojas Moreno, Adriana Patricia [1 ]
Elias Bruges, Ricardo [2 ,3 ]
Canas Arboleda, Alejandra [4 ,5 ]
Fernando Jaramillo, Luis [4 ,5 ]
机构
[1] Pontificia Univ Javeriana, Inst Genet Humana, Carrera 7 40-62,Edificio 32,2 piso, Bogota, Colombia
[2] Ctr Javeriano Oncol, Bogota, Colombia
[3] Inst Nacl Cancerol, Oncol, Bogota, Colombia
[4] Hosp Univ San Ignacio, Bogota, Colombia
[5] Pontificia Univ Javeriana, Bogota, Colombia
来源
UNIVERSITAS MEDICA | 2016年 / 57卷 / 03期
关键词
epigenetic repression; DNA methylation; histone code; lung neoplasms; chromatin;
D O I
10.11144/Javeriana.umed57-3.recp
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Lung cancer is the leading cause of malingnancy death worldwide. This phenomenon occurs when detected in the most advanced stages of the disease (stage III or IV). There are risk factors described in the generation of this cancer such us the consumption of tabacco, inhalation and subsequent accumulation of radon and asbestos in lung tissue, environmental pollution, the presence of genetic alterations, and the presence of epigenetic factors regulating the expression or repression of genes involved in tumor development. Epigenetic regulation mechanisms may get involved in tumor progression. They are DNA methylation, histone covalent modification and the presence of noncoding RNAs. At different stages of tumor progression it described, the involve of epigenetic mechanisms as regulators of processes related to proliferation, epithelial mesenchymal transition, metastasis, apoptosis, and others describes different stages of the tumor progression. This review focuses on describing the role of epigenetics in the progression of the lung tumor and remarks on the importance of enhancing knowledge in this discipline for diagnosis and treatment.
引用
收藏
页码:332 / 347
页数:16
相关论文
共 50 条
  • [41] Epigenetic regulation of prostate cancer: the theories and the clinical implications
    Liao, Yiji
    Xu, Kexin
    ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (03) : 279 - 290
  • [42] Cancer epigenetics as biomarkers of clinical significance
    Panayiotidis, Mihalis I.
    CANCER LETTERS, 2014, 342 (02) : 168 - 169
  • [43] Lung cancer epigenetics: From knowledge to applications
    Duruisseaux, Michael
    Esteller, Manel
    SEMINARS IN CANCER BIOLOGY, 2018, 51 : 116 - 128
  • [44] Expression profiling of lung cancer and its clinical implications
    Beer, DG
    LUNG CANCER, 2005, 49 : S14 - S15
  • [45] Biological and clinical implications of EGFR mutation in lung cancer
    Mitsudomi, Tetsuya
    CANCER SCIENCE, 2018, 109 : 1080 - 1080
  • [46] Clinical Implications of Circulating Circular RNAs in Lung Cancer
    Choi, Sae Seul
    Kim, Sae Eun
    Oh, Seon Young
    Ahn, Young-Ho
    BIOMEDICINES, 2022, 10 (04)
  • [47] Biological and clinical implications of EGFR mutations in lung cancer
    Mitsudomi T.
    Kosaka T.
    Yatabe Y.
    International Journal of Clinical Oncology, 2006, 11 (3) : 190 - 198
  • [48] On the Derivation and Clinical Implications of "Driver" Mutations in Lung Cancer
    Batra, Raj K.
    Warburton, David
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 182 (01) : 4 - 5
  • [49] The biology, function and clinical implications of exosomes in lung cancer
    Zhou, Li
    Lv, Tangfeng
    Zhang, Qun
    Zhu, Qingqing
    Zhan, Ping
    Zhu, Suhua
    Zhang, Jianya
    Song, Yong
    CANCER LETTERS, 2017, 407 : 84 - 92
  • [50] miRNA detection methods and clinical implications in lung cancer
    Uso, Marta
    Jantus-Lewintre, Eloisa
    Sirera, Rafael
    Bremnes, Roy M.
    Camps, Carlos
    FUTURE ONCOLOGY, 2014, 10 (14) : 2279 - 2292